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A B S T R A C T
Objective. To identify factors associated with fluoroscopy use in pediatric and congenital heart disease (CHD)
patients.
Design. Retrospective cohort.
Setting. Pediatric electrophysiology lab in a single tertiary-care children’s hospital.
Patients. Three hundred eighty-three patients who underwent electrophysiology study and ablation between
January 2010 and December 2012.
Methods. Ablation procedures in which nonfluoroscopic navigation was employed were reviewed. Procedures using
≥10 minutes of fluoroscopy (high-fluoroscopy time; HF) were compared with those using <10 minutes (low-
fluoroscopy time; LF). Group comparison of characteristics was made in the entire cohort and in CHD and
anatomically normal heart subsets.
Results. During the study period, 416 ablation procedures were performed involving 471 substrates in 383 patients.
Median fluoroscopy time was 6.7 minutes overall and 5.1 minutes with anatomically normal hearts. LF comprised
61% of all ablation and 69% of anatomically normal hearts. LF procedures were associated with anatomically normal
hearts (93% vs. 63%; P < .0001). In anatomically normal hearts, HF was associated with accessory pathways (64%
vs. 47%; P = .01), posteroseptal substrates (22% vs. 9%; P = .002), and ventricular substrates (12% vs. 1%; P < .0001).
All cases of intra-atrial reentrant tachycardia were HF. HF was associated with trans-septal puncture (47% vs. 23%;
P < .0001) though not when controlling for atrioventricular nodal reentrant tachycardia. LF was associated with
cryoablation (56% vs. 17%; P < .0001).
Conclusions. In pediatric and congenital EP, ablation procedures using cryoablation and in patients with anatomi-
cally normal hearts are associated with LF. In accessory pathway ablation, HF was not associated with trans-septal
puncture.
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Introduction
Catheter ablation in the pediatric and CHDpopulation has offered effective treatment for
arrhythmias for over 20 years.1–4 Its early reliance
on fluoroscopy-guided catheter navigation was
reduced with the implementation and advance-
ment of three-dimensional (3D)3 mapping
systems.5,6 Given the known risks of ionizing
radiation, particularly relevant to the pediatric
population, there has been an increasing effort
to limit its use.7–11 Indeed, the era of low and
even fluoroscopy-free electrophysiology study and
ablation procedures has arrived.12,13
A significant reduction in fluoroscopic exposure
has been demonstrated in these procedures when
employing 3D mapping and intracardiac ultra-
sound without a compromise in success rate or
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increase in procedure time.14,15 An increase in total
case duration due to increased setup and catheter
placement has, however, been noted. A recent
study characterized factors associated with
increased fluoroscopy time in a comparison
between conventional ablation and 3D mapping-
assisted ablation.16 A prospective randomized con-
trolled trial designed to assess this question is
ongoing.17 In laboratories employing concerted
low-fluoroscopy efforts, including the consistent
use of 3D mapping, the variables that characterize
electrophysiology cases failing to achieve single-
digit fluoroscopy times remain undefined.
Once radiation-reducing measures have been
optimized, the most operator-dependent and
generalizable metric of radiation use is fluoroscopy
time. The aim of this study was to identify signifi-
cant differences between high- and low-
fluoroscopy procedures in patient and procedural
characteristics that may contribute to fluoroscopy
use.
Methods
Patient Selection
In a retrospective cohort study, records from con-
secutive patients who underwent first-time abla-
tion at the University of Michigan Congenital
Heart Center from January 1, 2010, to December
31, 2012, were reviewed. Computerized 3D
mapping systems had been in consistent use in this
center for more than 5 years prior to the study
period. All patients who underwent catheter abla-
tion during the study period were included.
Mapping and Ablation Procedure
All cases reviewed involved the use of 3D mapping
with a capability of single or biplane conventional
fluoroscopy. Cases were performed by any of three
attending pediatric electrophysiologists, with the
assistance of fellow trainees.
Data Collection
Patients and procedures were identified from the
center’s database, and additional clinical data were
obtained from medical records. Patient and pro-
cedural factors were analyzed for the cohort as a
whole. The cohort was then divided into two
groups for comparison: a high-fluoroscopy time
group (HF), defined as receiving ≥10 minutes of
fluoroscopy time, and a low-fluoroscopy time
group (LF), who received <10 minutes of fluoros-
copy time.
Statistical Analysis
Data are presented as absolute number with per-
centage for categorical variables and median with
range or interquartile range for continuous vari-
ables. Patient and procedural characteristics of the
two fluoroscopy time groups (HF vs. LF) were
compared using χ2-test or Fisher’s exact test for
categorical variables and Wilcoxon rank-sum test
for continuous variables. Separate analyses were
completed for patients with anatomically normal
hearts and those with CHD. Odds ratio and 95%
confidence interval were also reported for the sub-
strates significantly associated with HF. The analy-
sis was completed based on the first procedure for
each patient. An additional analysis was completed
for all procedures during this time period, includ-
ing repeat ablations, with similar results (data not
shown). Logistic regression controlling for atrio-
ventricular nodal reentrant tachycardia (AVNRT),
using the Wilcoxon rank-sum test for continuous
variables, was performed to determine if the asso-
ciation between trans-septal puncture and the two
fluoroscopy groups was confounded by AVNRT.
All analyses were performed using SAS Version 9.3
(SAS Institute Inc., Cary, NC, USA), with statis-
tical significance set at a P value less than .05 using
a two-sided test.
Results
Case Characteristics
During the study period, first-time ablations were
performed on 383 patients, in whom a total of 432
arrhythmia substrates were addressed (339
patients with single substrates, 39 with two sub-
strates, and 5 with three). There were an addi-
tional 33 (8.6%) repeat ablations (with initial
ablations occurring before or during the study
period) that were excluded from the primary
analysis. Patients were 52% male with a median
age of 14.4 years (range 0.4–56.1) and median
weight of 55.1 kg at procedure (range 4.9–181.5)
(Table 1). Of the 383 patients, acute success was
achieved in 371 (97%). There were a total of 46
recurrences for all initial procedures in this group
(12%).
In the 311 patients with anatomically normal
hearts, 332 ablation procedures were performed,
addressing 359 substrates. In the 72 patients with
CHD, there were 84 ablations, addressing 112
substrates. Median fluoroscopy time for all
patients was 6.7 minutes (range 0–107) and 5.1
minutes (0–80) for those with anatomically normal
hearts. The skewed distribution of fluoroscopy
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time use is shown in Figure 1. There were 42
ablations (11%) performed without fluoroscopy.
Fluoroscopy time was less than 2 minutes in 107
ablations (28%). LF comprised 61% of all ablation
and 69% of ablation in anatomically normal
hearts.
Fluoroscopy use by substrate type and location
is shown in Figure 2. Ablation of accessory
pathway substrates had median fluoroscopy times
ranging from 5.0 (anteroseptal) to 9.9 (posterosep-
tal) minutes. Median fluoroscopy use for AVNRT
was 0.9 minutes; for intra-atrial reentrant tachy-
cardia (IART), atrial ectopic tachycardia (AET),
ventricular tachycardia (VT), and multiple sub-
strates, it ranged from 11.2 minutes (multiple sub-
strates) to 27.5 minutes (IART).
LF procedures were associated with anatomi-
cally normal hearts (93% vs. 63%; P < .0001). LF
was also highly associated with successful cases
(100% vs. 92%; P < .0001). There was an associa-
tion between HF and recurrence (16% vs. 9%;
P = .05). The odds ratios of significant associations
are shown in Table 2.
Anatomically Normal Hearts
Considering only anatomically normal hearts, HF
was associated with increased procedure duration.
Of 311 cases, 305 were acutely successful (98%).
LF was highly associated with successful cases
(100% vs. 94%; P = .001). In the anatomically
normal heart cohort, the recurrence rate was 9%
with no association between fluoroscopy use and
recurrence. There was no difference between the
groups with regard to attending electrophysiolo-
gist or the number of substrates addressed.
Excluding the 7 cases in which remote magnetic
or robotic navigation was used, the type of 3D
mapping technology was not significantly different
between the groups. Trans-septal puncture was
performed in a greater number of HF than LF
procedures (47% vs. 23%; P < .0001), though this
relation was lost after excluding AVNRT from the
Table 1. Demographic and Procedural Characteristics of Patients Who Underwent Pediatric Catheter Ablation
Characteristics All
High-fluoroscopy (≥10 min)
(n = 150)
Low-fluoroscopy (<10 min)
(n = 233) P†
Male sex 200 (52.2) 80 (53.3) 120 (51.5) .73
Caucasian race 326 (85.1) 128 (85.3) 198 (85.0) .34
Age at procedure (years) 14.4 (10.6–16.8) 15.0 14.2 .02*
Weight (kg) 55.1 (39.4–67.7) 58.7 54.1 .12
Height (cm) 163 (146–172) 162 163 .89
Body surface area (m2) 1.6 (1.3–1.8) 1.6 1.6 .19
Procedural
Total procedural time (min) 174 (120–244) 235 (170–309) 140 (108–195) <.0001*
Trans-septal puncture 116 (30.3) 65 (43.3) 51 (21.9) <.0001*
Substrate
Accessory pathway 176 (46.0) 68 (45.3) 108 (46.4) .85
Right free wall accessory pathway 29 (7.6) 9 (6.0) 20 (8.6) .35
Left free wall accessory pathway 91 (23.8) 35 (23.3) 56 (24.0) .88
Posterior septal accessory pathway 44 (11.5) 22 (14.7) 22 (9.4) .12
Anterior septal accessory pathway 12 (3.1) 2 (1.3) 10 (4.3) .14
Atrioventricular nodal reentrant tachycardia 118 (30.8) 14 (9.3) 104 (44.6) <.0001*
Atrial fibrillation 3 (0.8) 3 (2.0) 0 (0.0) .06
Intra-atrial reentrant tachycardia 24 (6.3) 24 (16.0) 0 (0.0) <.0001*
Atrial ectopic tachycardia 12 (3.1) 9 (6.0) 3 (1.3) .01*
Ventricular tachycardia 21 (5.5) 17 (11.3) 4 (1.7) <.0001*
Multiple 29 (7.6) 15 (10.0) 14 (6.0) .15
Left or right-sided substrate
Left 123 (32.1) 63 (42.0) 60 (25.8) .0001*
Right 248 (64.8) 76 (50.7) 172 (73.8) .0001*
Use of radiofrequency or cryo
Radiofrequency 194 (50.7) 100 (66.7) 94 (40.3) <.0001*
Cryo 150 (39.2) 23 (15.3) 127 (54.5) <.0001*
Complication 36 (9.4) 16 (10.7) 20 (8.6) .48
Anatomically normal heart (ANH) 311 (81.2) 95 (63.3) 216 (92.7) <.0001*
Post-procedural
Acute success 371(96.8) 138 (92.0) 233 (100.0) <.0001*
Recurrence 46 (12.0) 24 (16.0) 22 (9.4) .05*
Analysis based on the first procedure for each patient (n = 383).
Data are presented as n (%) for categorical variables and median (interquartile range) for continuous variables.
*P < .05.
†P value from χ2-test or Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous variables on comparison of each characteristic
between two fluoroscopy groups.
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analysis. HF was associated with posteroseptal
accessory pathways (22% vs. 9%; P = .002) and
ventricular substrates (12% vs. 1%; P < .0001).
When comparing all accessory pathways to other
ablation substrates, HF was associated with acces-
sory pathways (64% vs. 47%; P = .01). HF was
associated with left-sided substrates (52% vs. 27%;
P < .0001). LF was associated with cryoablation
(56% vs. 17%; P < .0001). The odds ratios of the
significant associations in this subset are shown in
Table 3. There was no statistically significant dif-
ference between the groups relative to pathway
(right free wall, left free wall, or anterior septal
accessory), though the difference in left free wall
pathways approached significance.
Congenitally Abnormal Hearts
In the procedures on patients with CHD, median
age trended higher in HF cases. In these patients,
66 of 72 cases had acute success (92%). There was
no association between fluoroscopy use and
success in this population. The recurrence rate was
24%, with a trend toward HF association with
recurrence (29% vs. 6%; P = .06) and older age (24
years vs. 17 years; P = .06). Excluding cases using
magnetic or robotic navigation, the type of 3D
Figure 1. Histogram of fluoroscopy times for the series.
Figure 2. Fluoroscopy use by substrate. The median is reported due to non-normal distribution. RFWAP, right free wall
accessory pathway; LFWAP, left free wall accessory pathway; PSAP, posteroseptal accessory pathway; ASAP, anteroseptal
accessory pathway; AVNRT, atrioventricular nodal reentrant tachycardia; IART, intra-atrial reentrant tachycardia; AET, atrial
ectopic tachycardia; VT, ventricular tachycardia; Multi, multiple substrates.
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mapping technology did segregate between
groups: HF with Carto (Carto XP and Carto 3,
Biosense-Webster, Inc., Diamond Bar, CA, USA)
and LF with Ensite (Ensite Velocity, St. Jude, Inc.,
St. Paul, MN, USA). HF was associated with
longer procedural duration (270 minutes vs. 150
minutes; P < .0001) and trans-septal puncture
(36% vs. 6%; P = .02). After excluding AVNRT
cases from the analysis, HF’s association with
trans-septal puncture was not significant (P = .09).
LF was associated with AVNRT (24% vs. 6%; P =
.05) and cryoablation (41% vs. 11%; P = .01). All
cases of IART were HF. The odds ratios of signifi-
cant associations in this subset are shown in
Table 4.
There were no major complications in either
group, and the overall rates of minor complica-
tions were similar.
Discussion
The current era of pediatric catheter ablation pro-
vides for low- or zero-fluoroscopy procedures.
Despite these procedural advances, cases involving
significant use of fluoroscopy remain. The data
presented describe the patient and procedural
characteristics associated with increased use of
fluoroscopy in a lab actively minimizing its use in
favor of 3D nonfluoroscopic alternatives.
Analyzing fluoroscopy time as continuous data
was considered, but the statistical tools available
for this variable with very nonnormal distribution
were complex. As such, we believed a nominal
comparison to be more clinically meaningful. The
10-minute threshold was selected as a round value
that divided the case series into comparable groups
and was a reasonable threshold separating cases of
lower and higher fluoroscopy use.
While there are many components (including
minutes, frame rate, beam strength, etc.) that con-
tribute to reduced radiation dose for a patient,
total minutes of fluoroscopy is the most
practitioner-dependent. Effective dose varies with
equipment age, manufacturer, and other features
Table 2. Demographic and Procedural Characteristics
Predicting High Fluoroscopy: All Patients, First Procedure
Only (n = 383)
Characteristics Odds Ratio
95%
Confidence
Interval
Age at procedure (years) 1.06 1.03, 1.09
Procedural
Total procedural time (min) 1.01 1.01, 1.02
Success 0.04 0, 0.17
Trans-septal puncture 2.73 1.75, 4.29
Substrate
Atrioventricular nodal reentrant
tachycardia
0.13 0.07, 0.23
Intra-atrial reentrant tachycardia 62.4 13.6, infinity
Atrial ectopic tachycardia 4.87 1.19, 28.5
Ventricular tachycardia 7.32 2.64, 25.8
Left or right-sided substrate
Left 2.38 1.53, 3.72
Right Reference
Use of radiofrequency or cryo
Radiofrequency 5.87 3.52, 10.1
Cryo Reference
Anatomically normal heart 0.14 0.07, 0.24
Post-procedural
Acute success 0.04 0, 0.17
Recurrence 1.83 0.98, 3.41
Only statistically significant analyses presented.
Table 3. Procedural Characteristics Predicting High Fluo-
roscopy: Patients with Anatomically Normal Hearts (n = 311)
Characteristics Odds Ratio
95%
Confidence
Interval
Total procedural time (min) 1.01 1.01, 1.02
Trans-septal puncture 2.99 1.79, 5.00
Substrate
Accessory pathway 2.01 1.23, 3.32
Posterior septal accessory pathway 2.78 1.42, 5.46
Atrioventricular nodal reentrant
tachycardia
0.15 0.07, 0.29
Atrial ectopic tachycardia 9.45 1.38, 186
Ventricular tachycardia 13.9 2.94, 132
Left or right-sided substrate
Left 3.16 1.90, 5.29
Right Reference
Use of RF or cryo
RF 4.57 2.53, 8.62
Cryo Reference
Post-procedural
Success 0.05 0, 0.27
Recurrence 0.85 0.34, 1.94
Only statistically significant analyses presented.
Table 4. Demographic and Procedural Characteristics
Predicting High Fluoroscopy: Patients with Congenital
Heart Disease (n = 72)
Characteristics Odds Ratio
95%
Confidence
Interval
Age at procedure (years) 1.05 1.00, 1.10
Procedural
Total procedural time (min) 1.02 1.01, 1.04
Trans-septal puncture 8.94 1.21, 402
Substrate
Atrioventricular nodal reentrant
tachycardia
0.19 0.03, 0.95
Intra-atrial re-entrant tachycardia 17.6 3.56, infinity
Use of RF or cryo
RF 5.63 1.29, 26.1
Cryo Reference
Only statistically significant analyses presented.
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selected by a facility or physician. Use of collima-
tion, beam filtering, and the lowest usable frame
rates all minimize radiation dose, in addition to
prudent fluoroscopy pedal use. It is the practice of
this lab to use 4 frames per second as a baseline
and increase to 15–30 frames per second for
precise catheter manipulations such as trans-septal
puncture.
Not surprisingly, this study confirms that the
use of fluoroscopy is higher in the congenital heart
population than in pediatric patients with ana-
tomically normal hearts. The small number of
cases (9 total) using technology integrating MRI,
CT, and real-time intravascular echo (ICE), which
offer improved navigation in complex anatomy,18
did not allow for an assessment of their impact on
fluoroscopy use.
In the anatomically normal heart cohort, there
were two key findings: (1) HF is associated with
use of radiofrequency (RF) ablation compared
with cryoablation; and (2) trans-septal puncture
does not confer HF even in the setting of a
fluoroscopy-guided puncture technique and fellow
involvement.
The first of these may be attributable primarily
to the almost exclusive performance of AVNRT
ablation using cryoablation. These cases, even
when of long duration and requiring many cryo
lesions, could be completed with minimal fluoros-
copy use. The safety of cryoablation allows for
reduced fluoroscopy once there is a decision that it
will be the ablation modality. We hypothesize that
the second of these findings, that trans-septal
punctures were found to a similar degree in HF
and LF groups, results from the fact that while
puncture was performed using fluoroscopy, the
left-sided substrates required less subsequent fluo-
roscopy than other substrates to ablate success-
fully. Though not a frequent practice of this lab, it
is possible that the use of ICE may serve to further
decrease fluoroscopy use.
For posterior septal accessory pathways, often
ablated with RF, HF may occur secondary to
efforts verifying catheter position and the chal-
lenges of mapping in this region. These cases may
therefore represent an opportunity to use cryoab-
lation and reduce fluoroscopy time significantly.
Both AET and VT showed increased use of
fluoroscopy, though they constitute a small minor-
ity of the substrates addressed. These too may
represent opportunities to reduce fluoroscopy
time, perhaps by relying more heavily on mapping
technologies, including automated pace mapping
(Carto Paso, Biosense-Webster) and noncontact
mapping (EnSite Velocity 3D Array, St. Jude)
technologies.
Congenital procedures involving not only
complex arrhythmias but also varied and complex
anatomy are notorious for prolonged case dura-
tion, another factor associated with increased fluo-
roscopy use. With multiple circuits to map, unique
chamber dimensions, and extensive ablation lines,
operators likely rely more heavily on fluoroscopy.
The study identified increased fluoroscopy use
with the Carto 3D mapping systems compared
with that of the Velocity/NavX. When looking at
the subanalysis of normal vs. congenital heart
disease, however, a difference was only seen in the
congenital heart group. This association is con-
founded by a selection bias: early in the cohort, it
was preferred to reserve the use of Carto XP for
cases in which point-by-point activation mapping
was anticipated. The ability of the system to visu-
alize only the ablation catheter necessitated the
use of fluoroscopy to position diagnostic catheters.
Given the goal of zero fluoroscopy use, the
Velocity/NavX was used for most other routine
ablations. With the introduction of the Carto 3
later in the experience, this system was used more
interchangeably with Velocity/NavX.
Study limitations include those inherent in a
retrospective study at a single center. The selec-
tion of 3D mapping system by the three attending
pediatric electrophysiologists was at times feature-
based and at others arbitrary. It was also not pos-
sible to control for the involvement of individual
operators, who included fellows and attending
physicians of varying experience, as their involve-
ment could not be quantified from records. Addi-
tionally, the use of fluoroscopy was not formalized
and, we suspect, was influenced by such factors as
involvement of trainees, the specific laboratory
used, and preferred equipment.
In conclusion, higher fluoroscopy exposure
was associated with procedures completed on
patients with CHD and those using RF rather
than cryoablation. Procedures involving an acces-
sory pathway and even trans-septal puncture did
not segregate into the high fluoroscopy time
group. Recognition of factors associated with HF
may assist in planning and executing ablation
with improved safety for the pediatric catheter
ablation patient. Anticipating minimal to no fluo-
roscopy use in cryoablation cases is reasonable
using modern 3D mapping systems. Expanding
the array of substrates addressed with cryoabla-
tion may be a means to reduce fluoroscopy use
significantly.
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